Development of a 3D model for the human cannabinoid CB1 receptor

Journal of Medicinal Chemistry

Volumn 47, Issue 12, 2004, Pages 3048-3057

  Salo, Outi M H ^a   Lahtela Kakkonen, Maija ^a   Gynther, Jukka ^a   Järvinen, Tomi ^a   Poso, Antti ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR AGONIST; DEXANABINOL; LIGAND; LYSINE; RIMONABANT;

ARTICLE; AUTOMATION; HUMAN; IMAGE ANALYSIS; MODEL; MOLECULAR DYNAMICS; NONHUMAN; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN STRUCTURE; SIMULATION; THREE DIMENSIONAL IMAGING; X RAY ANALYSIS;

AMINO ACID SEQUENCE; BINDING SITES; CANNABINOIDS; HUMANS; LIGANDS; MODELS, MOLECULAR; MOLECULAR CONFORMATION; MOLECULAR SEQUENCE DATA; RECEPTOR, CANNABINOID, CB1; RHODOPSIN; SEQUENCE ALIGNMENT;

EID: 2542572598     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm031052c     Document Type: Article

References (77)

1. Wise, A.; Gearing, K.; Rees, S. Target validation of G-protein coupled receptors. Drug Discovery Today 2002, 7, 235-246.
2. Pertwee, R. G. Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol. Ther. 1997, 74, 129-180.
3. Matsuda, L. A.; Lolait, S. J.; Brownstein, M. J.; Young, A. C.; Bonner, T. I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990, 346, 561-564.
4. Munro, S.; Thomas, K. L.; Abu-Shaar, M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993, 365, 61-65.
5. Devane, W. A.; Breuer, A.; Sheskin, T.; Jarbe, T. U.; Eisen, M. S.; Mechoulam, R. A novel probe for the cannabinoid receptor. J. Med. Chem. 1992, 35, 2065-2069.
6. Sugiura, T.; Kondo, S.; Sukagawa, A.; Nakane, S.; Shinoda, A.; Itoh, K.; Yamashita, A.; Waku, K. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem. Biophys. Res. Commun. 1995, 215, 89-97.
7. Mechoulam, R.; Ben-Shabat, S.; Hanus, L.; Ligumsky, M.; Kaminski, N. E.; Schatz, A. R.; Gopher, A.; Almog, S.; Martin, B. R.; Compton, D. R.; Pertwee, R. G.; Griffin, G.; Bayewitch, M.; Barg, J.; Vogel, Z. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol. 1995, 50, 83-90.
8. Hanus, L.; Abu-Lafi, S.; Fride, E.; Breuer, A.; Vogel, Z.; Shalev, D. E. ; Kustanovich, I.; Mechoulam, R. 2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor. Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 3662-3665.
9. Porter, A. C.; Sauer, J. M.; Knierman, M. D.; Becker, G. W.; Berna, M. J.; Bao, J.; Nomikos, G. G.; Carter, P.; Bymaster, F. P.; Leese, A. B.; Felder, C. C. Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor. J. Pharmacol. Exp. Ther. 2002, 301, 1020-1024.
10. Huang, S. M.; Bisogno, T.; Trevisani, M.; Al-Hayani, A.; De Petrocellis, L.; Fezza, F.; Tognetto, M.; Petros, T. J.; Krey, J. F.; Chu, C. J.; Miller, J. D.; Davies, S. N.; Geppetti, P.; Walker, J. M.; Di Marzo, V. An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors. Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 8400-8405.
11. Gaoni, Y.; Mechoulam, R. Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish. J. Am. Chem. Soc. 1964, 86, 1646-1647.
12. Baker, D.; Pryce, G.; Giovannoni, G.; Thompson, A. J. The terapeutic potential of cannabis. Lancet Neurol. 2003, 2, 291-298.
13. Bramblett, R. D.; Panu, A. M.; Ballesteros, J. A.; Reggio, P. H. Construction of a 3D model of the cannabinoid CB1 receptor: determination of helix ends and helix orientation. Life Sci. 1995, 56, 1971-1982.
14. Song, Z. H.; Slowey, C. A.; Hurst, D. P.; Reggio, P. H. The difference between the CB(1) and CB(2) cannabinoid receptors at position 5.46 is crucial for the selectivity of WIN55212-2 for CB(2). Mol. Pharmacol. 1999, 56, 834-840.
15. Schertler, G. F.; Villa, C.; Henderson, R. Projection structure of rhodopsin. Nature 1993, 362, 770-772.
16. Baldwin, J. M. The probable arrangement of the helices in G protein-coupled receptors. EMBO J. 1993, 12, 1693-1703.
17. McAllister, S. D.; Tao, Q.; Barnett-Norris, J.; Buehner, K.; Hurst, D. P.; Guarnieri, F.; Reggio, P. H.; Nowell Harmon, K. W.; Cabral, G. A.; Abood, M. E. A critical role for a tyrosine residue in the cannabinoid receptors for ligand recognition. Biochem. Pharmacol. 2002, 63, 2121-2136.
18. Mahmoudian, M. The cannabinoid receptor: computer-aided molecular modeling and docking of ligand. J. Mol. Graph. Model. 1997, 15, 149-153, 179.
19. Zhang, D.; Weinstein, H. Polarity conserved positions in transmembrane domains of G-protein coupled receptors and bacteriorhodopsin. FEBS Lett. 1994, 337, 207-212.
20. Palczewski, K.; Kumasaka, T.; Hori, T.; Behnke, C. A.; Motoshima, H.; Fox, B. A.; Le Trong, I.; Teller, D. C.; Okada, T.; Stenkamp, R. E.; Yamamoto, M.; Miyano, M. Crystal structure of rhodopsin: A G protein-coupled receptor. Science 2000, 289, 739-745.
21. Ballesteros, J.; Palczewski, K. G protein-coupled receptor drug discovery: implications from the crystal structure of rhodopsin. Curr. Opin. Drug Discovery Dev. 2001, 4, 561-574.
22. Ballesteros, J. A.; Shi, L.; Javitch, J. A. Structural mimicry in G protein-coupled receptors: implications of the high-resolution structure of rhodopsin for structure-function analysis of rhodopsin-like receptors. Mol. Pharmacol. 2001, 60, 1-19.
23. Bissantz, C.; Bernard, P.; Hibert, M.; Rognan, D. Protein-based virtual screening of chemical databases. II. Are homology models of G-Protein Coupled Receptors suitable targets? Proteins 2003, 50, 5-25.
24. Barnett-Norris, J.; Hurst, D. P.; Lynch, D. L.; Guarnieri, F.; Makriyannis, A.; Reggio, P. H. Conformational memories and the endocannabinoid binding site at the cannabinoid CB1 receptor. J. Med. Chem. 2002, 45, 3649-3659.
25. Shim, J. Y.; Welsh, W. J.; Howlett, A. C. Homology model of the CB1 cannabinoid receptor: Sites critical for nonclassical cannabinoid agonist interaction. Biopolymers 2003, 71, 169-189.
26. Baldwin, J. M.; Schertler, G. F.; Unger, V. M. An alpha-carbon template for the transmembrane helices in the rhodopsin family of G-protein-coupled receptors. J. Mol. Biol. 1997, 272, 144-164.
27. Mirzadegan, T.; Benko, G.; Filipek, S.; Palczewski, K. Sequence analyses of G-protein-coupled receptors: similarities to rhodopsin. Biochemistry 2003, 42, 2759-2767.
28. Gouldson, P.; Calandra, B.; Legoux, P.; Kerneis, A.; Rinaldi-Carmona, M. ; Barth, F.; Le Fur, G.; Ferrara, P.; Shire, D. Mutational analysis and molecular modelling of the antagonist SR 144528 binding site on the human cannabinoid CB(2) receptor. Eur. J. Pharmacol. 2000, 401, 17-25.
29. Shire, D.; Calandra, B.; Bouaboula, M.; Barth, F.; Rinaldi-Carmona, M.; Casellas, P.; Ferrara, P. Cannabinoid receptor interactions with the antagonists SR 141716A and SR 144528. Life Sci. 1999, 65, 627-635.
30. Shire, D.; Calandra, B.; Delpech, M.; Dumont, X.; Kaghad, M.; Le Fur, G. ; Caput, D.; Ferrara, P. Structural features of the central cannabinoid CB1 receptor involved in the binding of the specific CB1 antagonist SR 141716A. J. Biol. Chem. 1996, 271, 6941-6946.
31. Kleywegt, G. J.; Jones, T. A. Phi/Psi-chology: Ramachandran revisited. Structure 1996, 4, 1395-1400.
32. Reggio, P. H. Pharmacophores for ligand recognition and activation/inactivation of the cannabinoid receptors. Curr. Pharm. Des. 2003, 9, 1607-1633.
33. Jensen, A. D.; Guarnieri, F.; Rasmussen, S. G. F.; Asmar, F.; Ballesteros, J. A.; Gether, U. Agonist-induced conformational changes at the cytoplasmic side of transmembrane segment 6 in the beta(2) adrenergic receptor mapped by site-selective fluorescent labeling. J. Biol. Chem. 2001, 276, 9279-9290.
34. Barnett-Norris, J.; Hurst, D. P.; Buehner, K.; Ballesteros, J. A.; Guarnieri, F.; Reggio, P. H. Agonist alkyl tail interaction with cannabinoid CB1 receptor V6.43/I6.46 groove induces a helix 6 active conformation. Int. J. Quantum Chem. 2002, 88, 76-86.
35. Singh, R.; Hurst, D. P.; Barnett-Norris, J.; Lynch, D. L.; Reggio, P. H. ; Guarnieri, F. Activation of the cannabinoid CB1 receptor may involve a W6.48/F3.36 rotamer toggle switch. J. Pept. Res. 2002, 60, 357-370.
36. Song, Z. H.; Bonner, T. I. A lysine residue of the cannabinoid receptor is critical for receptor recognition by several agonists but not WIN55212-2. Mol. Pharmacol. 1996, 49, 891-896.
37. McAllister, S. D.; Hurst, D.; Buehner, K.; Norris, J. B.; Reggio, P. H.; Abood, M. E. Aromatic residues in helixes 3-5-6 of CB1 provide specific interaction sites for WIN55,212-2 and SR141716A. 2002 Symposium on the Cannabinoids; International Cannabinoid Research Society, Burlington, VT, 2002; p 76.
38. McAllister, S. D.; Rizvi, G.; Anavi-Goffer, S.; Hurst, D. P.; Barnett-Norris, J.; Lynch, D. L.; Reggio, P. H.; Abood, M. E. An aromatic microdomain at the cannabinoid CB(1) receptor constitutes an agonist/inverse agonist binding region. J. Med. Chem. 2003, 46, 5139-5152.
39. Huffman, J. W.; Yu, S.; Showalter, V.; Abood, M. E.; Wiley: J. L.; Compton, D. R.; Martin, B. R.; Bramblett, R. D.; Reggio, P. H. Synthesis and pharmacology of a very potent cannabinoid lacking a phenolic hydroxyl with high affinity for the CB2 receptor. J. Med. Chem. 1996, 39, 3875-3877.
40. Hart, R.; Hurst, D. P.; Reggio, P. The CB1 TMH 2-3 region forms the binding site for (+)-7-OH-CBD-DMH. 2003 Symposium on the Cannabinoids; International Cannabinoid Research Society, Burlington, VT, 2003; p 76.
41. Huffman, J. W.; Mabon, R.; Wu, M. J.; Lu, J.; Hart, R.; Hurst, D. P.; Reggio, P. H.; Wiley, J. L.; Martin, B. R. 3-Indolyl-1-naphthylmethanes: new cannabimimetic indoles provide evidence for aromatic stacking interactions with the CB(1) cannabinoid receptor. Bioorg. Med. Chem. 2003, 11, 539-549.
42. Shim, J. Y.; Howlett, A. Prediction of the CB1 cannabinoid receptor region critical for the binding of aminoalkylindole (AAI) WIN55212-2. 2003 Symposium on the Cannabinoids; International Cannabinoid Research Society, Burlington, VT, 2003; p 9.
43. Chin, C. N., Lucas-Lenard, J.; Abadji, V.; Kendall, D. A. Ligand binding and modulation of cyclic AMP levels depend on the chemical nature of residue 192 of the human cannabinoid receptor 1. J. Neurochem. 1998, 70, 366-373.
44. MacLennan, S. J.; Reynen, P. H.; Kwan, J.; Bonhaus, D. W. Evidence for inverse agonism of SR141716A at human recombinant cannabinoid CB1 and CB2 receptors. Br. J. Pharmacol. 1998, 124, 619-622.
45. Shim, J. Y.; Welsh, W. J.; Cartier, E.; Edwards, J. L.; Howlett, A. C. Molecular interaction of the antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl) -4-methyl-1H-pyrazole-3-carboxamide with the CB1 cannabinoid receptor. J. Med. Chem. 2002, 45, 1447-1459.
46. Hurst, D. P.; Lynch, D. L.; Barnett-Norris, J.; Hyatt, S. M.; Seltzman, H. H.; Zhong, M.; Song, Z. H.; Nie, J.; Lewis, D.; Reggio, P. H. N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl) -4-methyl-1H-pyrazole-3-carboxamide (SR141716A) interaction with LYS 3.28(192) is crucial for its inverse agonism at the cannabinoid CB1 receptor. Mol. Pharmacol. 2002, 62, 1274-1287.
47. Bairoch, A.; Apweiler, R. The SWISS-PROT protein sequence database and its supplement TrEMBL in 2000. Nucleic Acids Res. 2000, 28, 45-48.
48. Berman, H. M.; Battistuz, T.; Bhat, T. N.; Bluhm, W. F.; Bourne, P. E.; Burkhardt, K.; Feng, Z.; Gilliland, G. L.; Iype, L.; Jain, S.; Fagan, P.; Marvin, J.; Padilla, D.; Ravichandran, V.; Schneider, B.; Thanki, N.; Weissig, H.; Westbrook, J. D.; Zardecki, C. The Protein Data Bank. Acta Crystallogr. D Biol. Crystallogr. 2002, 58, 899-907.
49. Thompson, J. D.; Higgins, D. G.; Gibson, T. J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 1994, 22, 4673-4680.
50. CLUSTAL W (version 1.82): http://www.ebi.ac.uk/clustalw/ (default settings: matrix, Blosum series; gap opening penalty, 10; gap extension penalty, 0.05).
51. Sybyl v. 6.9; Tripos Associates, Inc.: St, Louis, MO.
52. InsightII v. 2000; Accelrys, Inc.: San Diego, CA.
53. Weiner, S. J.; Kollman, P. A.; Case, D. A.; Singh, U. C.; Ghio, C.; Alagona, G.; Profeta, S.; Weiner, J. P. A new force field for molecular mechanical simulation of nucleic acids and proteins. J. Am. Chem. Soc. 1984, 106, 765-784.
54. Weiner, S. J.; Kollman, P. A.; Nguyen, D. T.; Case, D. A. An all atom force field for simulations of proteins and nucleic acids. J. Comput. Chem. 1986, 7, 230-252.
55. Besler, B. H.; Merz, K. M.; Kollman, P. A. Atomic charges derived from semiempirical methods. J. Comput. Chem. 1990, 11, 431-439.
56. GROMACS, v. 3.1.4; Department of Biophysical Chemistry, University of Groningen, Nijenborgh 4, 9747 AG Groningen, The Netherlands (http://www.gromacs.org/).
57. Lindahl, E.; Hess, B.; van der Spoel, D. GROMACS 3.0: A package for molecular simulation and trajectory analysis. J. Mol. Mod. 2001, 7, 306-317.
58. GOLD v. 2.0; Cambridge Crystallographic Data Centre: Cambridge, U.K.
59. CScore: http://www.tripos.com/sciTech/inSilicoDisc/virtualScreening/cscore. html#references.
60. Laskowski, R. A.; MacArthur, M. W.; Moss, D. S.; Thornton, J. M. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 1993, 26, 283-291.
61. Ballesteros, J. A.; Weinstein, H. W. Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G-protein coupled receptors. In Methods in Neuroscience; Sealfon, S. C., Ed.; Academic Press: San Diego, 1995; pp 366-428.
62. Teller, D. C.; Okada, T.; Behnke, C. A.; Palezewski, K.; Stenkamp, R. E. Advances in determination of a high-resolution three-dimensional structure of rhodopsin, a model of G-protein-coupled receptors (GPCRs). Biochemistry 2001, 40, 7761-7772.
63. Altschul, S. F.; Madden, T. L.; Schaffer, A. A.; Zhang, J.; Zhang, Z.; Miller, W.; Lipman, D. J. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 1997, 25, 3389-3402.
64. PSI-BLAST: http://www.ncbi.nlm.nih.gov/BLAST/(default settings; matrix, Blosum62).
65. SWISS-PROT: CB1R_HUMAN (P21554), CB1R_RAT (P20272), CB1R_FELCA (O02777), CB1R_POEGU (P56971), CB1R_TARGR (Q9PUI7), CB1A_FUGRU (Q98894), CB1B_FUGRU (Q98895), CB2R_RAT (Q9QZN9), CB2R_MOUSE (P47936), CB2R_HUMAN (P34972), HH1R_BOVIN (P30546), EDG1_RAT (P48303), MC5R_RAT (P35345), OPSD_BOVIN (P02699).
66. Essman, U.; Perela, L.; Berkowitz, M. L.; Darden, T.; Lee, H.; Pedersen, L. G. A smooth particle mesh Ewald method. J. Chem. Phys. 1995, 103, 8577-8592.
67. Berendsen, H. J. C.; Postma, J. P. M.; DiNola, A.; Haak, J. R. Molecular dynamics with coupling to an external bath. J. Chem. Phys. 1984, 81, 3684-3690.
68. Jorgensen, W. L.; Chandrasekhar, J.; Madura, J. D.; Impey, R. W.; Klein, M. L. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 1983, 79, 926-935.
69. Jorgensen, W. L.; Maxwell, D. S.; Tirado-Rives, J. Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids. J. Am. Chem. Soc. 1996, 118, 11225-11236.
70. Kony, D.; Damm, W.; Stoll, S.; Van Gunsteren, W. F. An improved OPLS-AA force field for carbohydrates. J. Comput. Chem. 2002, 23, 1416-1429.
71. van Gunsteren, W. F.; Berendsen, H. J. C. Gromos-87 manual; Biomos BV Nijenborgh 4, 9747 AG Groningen, The Netherlands, 1987.
72. Visual Data; Visipoint Oy, Kuopio, Finland (http://www.visi-point.fi).
73. Kohonen, T. Self-Organizing Maps, 2nd ed.; Springer-Verlag: Berlin, 1997.
74. McDonald, I. K.; Thornton, J. M. Satisfying hydrogen bonding potential in proteins. J. Mol. Biol. 1994, 238, 777-793.
75. Burley, S. K.; Petsko, G. A. Aromatic-aromatic interaction: a mechanism of protein structure stabilization. Science 1985, 229, 23-28.
76. Hunter, C. A.; Singh, J.; Thornton, J. M. Pi-pi interactions: the geometry and energetics of phenylalanine-phenylalanine interactions in proteins. J. Mol. Biol. 1991, 218, 837-846.
77. Connolly, M. L. Solvent-accessible surfaces of proteins and nucleic acids. Science 1983, 221, 709-713.